SCHEMBL2802501

SCHEMBL2802501

O=C1CCCN1CCCNc1ncc2c(n1)-c1ccccc1C(c1ccccc1Cl)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYRO3 Q06418 13/20 0.47
MALT1 Q9UDY8 1/20 0.46
MKNK1 Q9BUB5 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
STK4 Q13043 1/20 0.44
STK3 Q13188 1/20 0.44
SIK2 Q9H0K1 1/20 0.44
STK26 Q9P289 1/20 0.44
STK24 Q9Y6E0 1/20 0.44
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
EGFR P00533 2/20 0.41
FGFR1 P11362 1/20 0.41
SRC P12931 1/20 0.41
FGFR2 P21802 1/20 0.41
FGFR4 P22455 1/20 0.41
FGFR3 P22607 1/20 0.41
CASK O14936 2/20 0.40
ABL1 P00519 1/20 0.40
NTRK1 P04629 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2804619 0.90 CSF1R (0.48) TYRO3MALT1MKNK1MKNK2STK4
SCHEMBL2803919 0.90 FGFR1 (0.48) TYRO3MALT1MKNK1MKNK2STK4
SCHEMBL2806566 0.87 MALT1 (0.44) TYRO3MALT1MKNK1MKNK2STK4
SCHEMBL2804113 0.87 FGFR1 (0.46) EGFRFGFR1SRCFGFR2FGFR4
SCHEMBL2807020 0.84 FGFR1 (0.54) EGFRFGFR1SRCFGFR2FGFR4
SCHEMBL2804075 0.82 FGFR1 (0.52) TYRO3STK4STK3SIK2STK26
SCHEMBL17057491 0.81 FGFR1 (0.45) EGFRFGFR1SRCFGFR2FGFR4
SCHEMBL2806766 0.78 FGFR1 (0.41) EGFRFGFR1SRCFGFR2FGFR4
SCHEMBL2804796 0.77 FGFR1 (0.49) EGFRFGFR1SRCFGFR2FGFR4
SCHEMBL2803090 0.76 FGFR1 (0.54) TYRO3FGFR1FGFR2FGFR3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 TYRO3 2026/4885MALT1 1622/4885MKNK1 2646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.